Related Experiment Video
Updated: Dec 30, 2025

Differentiation of Human Pluripotent Stem Cells into Insulin-Producing Islet Clusters
Published on: June 23, 2023
The De-, Re-, and trans-differentiation of β-cells: Regulation and function
1Department of Metabolism & Endocrinology, the Second Xiangya Hospital, National Clinical Research Center for Metabolic Diseases, Central South University, Changsha, Hunan, 410011, China; Metabolic Syndrome Research Center, Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, Central South University, Changsha, Hunan, 410011, China.
Abstract:
Diabetes is a serious, costly, and major health problem worldwide. Whereas diabetes could be alleviated by medication, this disease could not be fully cured at the present time due to the lack of effective therapeutic treatment for β-cell loss and/or dysfunction. Increased β-cell mass or volume could be achieved via differentiation of embryonic stem (ES) cells or pluripotent stem cells or through β-cell renewal, including proliferation, redifferentiation, and transdifferentiation. Data cumulated over the past several years suggest that increased β-cell dedifferentiation plays a crucial role in the progression of diabetes, shedding new light on potential targets for β-cell replacement therapy. In this review, we summarize current views on β-cell dedifferentiation, redifferentiation, and transdifferentiation. We also discuss potential mechanisms regulating these key processes to maintain β-cell homeostasis. Understanding pancreatic β-cell differentiation and dedifferentiation could be provide important information on developing effective strategies to cure diabetes.
Insights
Diabetes treatment faces challenges due to beta-cell loss. Understanding beta-cell dedifferentiation and renewal offers new therapeutic targets for curing diabetes.
Area of Science:
- Endocrinology and Metabolism
- Stem Cell Biology
- Regenerative Medicine
Background:
- Diabetes mellitus is a global health crisis with significant economic burden.
- Current treatments manage but do not cure diabetes due to limitations in addressing beta-cell loss and dysfunction.
- Restoring beta-cell mass through stem cell differentiation or beta-cell renewal is a key therapeutic goal.
Purpose of the Study:
- To review current understanding of beta-cell dedifferentiation, redifferentiation, and transdifferentiation.
- To explore mechanisms regulating these processes in maintaining beta-cell homeostasis.
- To highlight the potential of these processes for developing novel diabetes therapies.
Main Methods:
- Literature review of recent research on pancreatic beta-cell biology.
- Synthesis of data on stem cell differentiation and beta-cell renewal pathways.
- Analysis of regulatory mechanisms involved in beta-cell dedifferentiation and redifferentiation.
Main Results:
- Beta-cell dedifferentiation is implicated in diabetes progression.
- Stem cell differentiation, proliferation, redifferentiation, and transdifferentiation are pathways to increase beta-cell mass.
- Understanding these processes is crucial for beta-cell replacement strategies.
Conclusions:
- Beta-cell dedifferentiation plays a critical role in diabetes.
- Targeting beta-cell dedifferentiation, redifferentiation, and transdifferentiation holds promise for diabetes cure.
- Further research into beta-cell homeostasis mechanisms can inform effective therapeutic development.
Related Concept Videos
Forced Transdifferentiation
Artificial...
Tissue Renewal without Stem Cells
However, failure of such a system...
Cellular Differentiation
A zygote is a...
iPS Cell Differentiation
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Feedback Loops

